BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 12108550)

  • 1. Stage-specific antimalarial activity of cysteine protease inhibitors.
    Shenai BR; Semenov AV; Rosenthal PJ
    Biol Chem; 2002 May; 383(5):843-7. PubMed ID: 12108550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmodium falciparum: effects of proteinase inhibitors on globin hydrolysis by cultured malaria parasites.
    Rosenthal PJ
    Exp Parasitol; 1995 Mar; 80(2):272-81. PubMed ID: 7895837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Plasmodium falciparum oocyst production by membrane-permeant cysteine protease inhibitor E64d.
    Eksi S; Czesny B; van Gemert GJ; Sauerwein RW; Eling W; Williamson KC
    Antimicrob Agents Chemother; 2007 Mar; 51(3):1064-70. PubMed ID: 17178799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Falcipains and other cysteine proteases of malaria parasites.
    Rosenthal PJ
    Adv Exp Med Biol; 2011; 712():30-48. PubMed ID: 21660657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Plasmodium falciparum cysteine protease falcipain-2 captures its substrate, hemoglobin, via a unique motif.
    Pandey KC; Wang SX; Sijwali PS; Lau AL; McKerrow JH; Rosenthal PJ
    Proc Natl Acad Sci U S A; 2005 Jun; 102(26):9138-43. PubMed ID: 15964982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmodium falciparum cysteine protease falcipain-1 is not essential in erythrocytic stage malaria parasites.
    Sijwali PS; Kato K; Seydel KB; Gut J; Lehman J; Klemba M; Goldberg DE; Miller LH; Rosenthal PJ
    Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8721-6. PubMed ID: 15166288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Plasmodium falciparum digestive vacuole plasmepsins in the specificity and antimalarial mode of action of cysteine and aspartic protease inhibitors.
    Moura PA; Dame JB; Fidock DA
    Antimicrob Agents Chemother; 2009 Dec; 53(12):4968-78. PubMed ID: 19752273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antimalarial effects of phenothiazine inhibitors of a Plasmodium falciparum cysteine protease.
    Domínguez JN; López S; Charris J; Iarruso L; Lobo G; Semenov A; Olson JE; Rosenthal PJ
    J Med Chem; 1997 Aug; 40(17):2726-32. PubMed ID: 9276017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimalarial activities of novel synthetic cysteine protease inhibitors.
    Lee BJ; Singh A; Chiang P; Kemp SJ; Goldman EA; Weinhouse MI; Vlasuk GP; Rosenthal PJ
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3810-4. PubMed ID: 14638488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prodomain peptide of Plasmodium falciparum cysteine protease (falcipain-2) inhibits malaria parasite development.
    Korde R; Bhardwaj A; Singh R; Srivastava A; Chauhan VS; Bhatnagar RK; Malhotra P
    J Med Chem; 2008 Jun; 51(11):3116-23. PubMed ID: 18461922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A malarial cysteine proteinase is necessary for hemoglobin degradation by Plasmodium falciparum.
    Rosenthal PJ; McKerrow JH; Aikawa M; Nagasawa H; Leech JH
    J Clin Invest; 1988 Nov; 82(5):1560-6. PubMed ID: 3053784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cysteine proteases of malaria parasites.
    Rosenthal PJ
    Int J Parasitol; 2004 Dec; 34(13-14):1489-99. PubMed ID: 15582526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemoglobin Degrading Proteases of Plasmodium falciparum as Antimalarial Drug Targets.
    Qidwai T
    Curr Drug Targets; 2015; 16(10):1133-41. PubMed ID: 25738296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimalarial effects of peptide inhibitors of a Plasmodium falciparum cysteine proteinase.
    Rosenthal PJ; Wollish WS; Palmer JT; Rasnick D
    J Clin Invest; 1991 Nov; 88(5):1467-72. PubMed ID: 1939639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimalarial effects of vinyl sulfone cysteine proteinase inhibitors.
    Rosenthal PJ; Olson JE; Lee GK; Palmer JT; Klaus JL; Rasnick D
    Antimicrob Agents Chemother; 1996 Jul; 40(7):1600-3. PubMed ID: 8807047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of efficacies of cysteine protease inhibitors against five strains of Plasmodium falciparum.
    Singh A; Rosenthal PJ
    Antimicrob Agents Chemother; 2001 Mar; 45(3):949-51. PubMed ID: 11181388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene disruption confirms a critical role for the cysteine protease falcipain-2 in hemoglobin hydrolysis by Plasmodium falciparum.
    Sijwali PS; Rosenthal PJ
    Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4384-9. PubMed ID: 15070727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for the protease falcipain 1 in host cell invasion by the human malaria parasite.
    Greenbaum DC; Baruch A; Grainger M; Bozdech Z; Medzihradszky KF; Engel J; DeRisi J; Holder AA; Bogyo M
    Science; 2002 Dec; 298(5600):2002-6. PubMed ID: 12471262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmodium falciparum: biochemical characterization of the cysteine protease falcipain-2'.
    Singh N; Sijwali PS; Pandey KC; Rosenthal PJ
    Exp Parasitol; 2006 Mar; 112(3):187-92. PubMed ID: 16337629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biosynthesis, localization, and processing of falcipain cysteine proteases of Plasmodium falciparum.
    Dahl EL; Rosenthal PJ
    Mol Biochem Parasitol; 2005 Feb; 139(2):205-12. PubMed ID: 15664655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.